Page last updated: 2024-11-12

thienopyrimidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

thienopyrimidine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

thienopyrimidine : A class of aromatic heterobicyclic compounds each of which contains a pyrimidine ring ortho fused to a 5-membered thiophene ring. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID12603004
SCHEMBL ID32388
SCHEMBL ID11206891
MeSH IDM0452231

Synonyms (16)

Synonym
AKOS006307947
thieno[3,2-d]pyrimidine
272-68-4
RBNBDIMXFJYDLQ-UHFFFAOYSA-N
thienopyrimidine
SCHEMBL32388
SCHEMBL11206891
DTXSID50504083
mfcd11110439
7-thieno[3,2-d]pyrimidine
A923878
AS-41229
CS-0088133
thiophenopyrimidine
EN300-101397
SY139048

Research Excerpts

Overview

The thienopyrimidine TP053 is an antitubercular prodrug active against both replicating and nonreplicating.

ExcerptReferenceRelevance
"The thienopyrimidine TP053 is an antitubercular prodrug active against both replicating and nonreplicating "( New Insights into the Mechanism of Action of the Thienopyrimidine Antitubercular Prodrug TP053.
Azhikina, T; Buzzi, A; Chiarelli, LR; Degiacomi, G; Forbak, M; Gosetti, F; Grigorov, A; Korduláková, J; Lepioshkin, A; Madacki, J; Makarov, V; Manfredi, M; Marengo, E; Mikušová, K; Mori, G; Orena, BS; Pasca, MR; Riabova, O; Riccardi, G; Salina, EG; Sammartino, JC, 2020
)
1.37

Bioavailability

ExcerptReferenceRelevance
"This research aimed to improve water solubility and oral bioavailability of a newly synthesized thienopyrimidine derivative (TPD) with anti-pancreatic cancer activity by loading on starch nanoparticles (SNPs)."( Starch Nanoparticles for Enhancement of Oral Bioavailability of a Newly Synthesized Thienopyrimidine Derivative with Anti-Proliferative Activity Against Pancreatic Cancer.
Gad, S; Gardouh, AR; Moustafa, Y; Salem, MSH; Srag El-Din, ASG, 2021
)
1.06
"The Swiss ADME results showed that TPD can be administered orally; however, it has low oral bioavailability (0."( Starch Nanoparticles for Enhancement of Oral Bioavailability of a Newly Synthesized Thienopyrimidine Derivative with Anti-Proliferative Activity Against Pancreatic Cancer.
Gad, S; Gardouh, AR; Moustafa, Y; Salem, MSH; Srag El-Din, ASG, 2021
)
0.85
"SNPs-TPD were superior in drug solubility and oral bioavailability than those obtained from TPD suspension."( Starch Nanoparticles for Enhancement of Oral Bioavailability of a Newly Synthesized Thienopyrimidine Derivative with Anti-Proliferative Activity Against Pancreatic Cancer.
Gad, S; Gardouh, AR; Moustafa, Y; Salem, MSH; Srag El-Din, ASG, 2021
)
0.85

Dosage Studied

ExcerptRelevanceReference
" The most active compound, 2-[2-(5-nitro-1H-benzimidazol-1-yl)ethyl]-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one 22 revealed 95% activity at a dosage of 5 mg/kg mw after 24 h, while compounds 8 and 10 applied at the same dose showed efficacy of 90% after 48 h."( Synthesis, antitrichinnellosis and antiprotozoal activity of some novel thieno[2,3-d]pyrimidin-4(3H)-ones containing benzimidazole ring.
Anichina, K; Mavrova, ATs; Vassilev, N; Vuchev, D, 2010
)
0.36
" A UV spectroscopy method was developed and validated to measure TPD concentration at various dosage forms."( Starch Nanoparticles for Enhancement of Oral Bioavailability of a Newly Synthesized Thienopyrimidine Derivative with Anti-Proliferative Activity Against Pancreatic Cancer.
Gad, S; Gardouh, AR; Moustafa, Y; Salem, MSH; Srag El-Din, ASG, 2021
)
0.85
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (123)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's24 (19.51)29.6817
2010's72 (58.54)24.3611
2020's27 (21.95)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.10

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.10 (24.57)
Research Supply Index4.87 (2.92)
Research Growth Index4.79 (4.65)
Search Engine Demand Index34.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.10)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews7 (5.43%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other122 (94.57%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]